Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-24-103037

Chief Medical Officer acquired 47,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kerr Douglas · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-09-03 Grant or award : show line 1 in the form +47,500 47,500 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-09-03 Grant or award : show line 2 in the form Stock Option (Right to Buy) +150,300 150,300 D
Loading xslF345X05/ownership.xml…